Neuro Flashcards
(201 cards)
Approximately 10% of (what tumor?) produce an erythropoietin-like protein that results in secondary polycythemia vera.
Approximately 10% of hemangioblastomas produce an erythropoietin-like protein that results in secondary polycythemia vera.
Brain invasive meningiomas are considered WHO grade ___?
Brain invasive meningiomas are considered WHO grade II. Atypical meningiomas are also WHO grade II. Anaplastic (malignant) meningiomas are WHO grade III.
Chordoma. Definition, Incidence and Location, Gender and Age Distribution, Clinical Features, Radiologic Features, and Prognosis and Treatment.
Definition: Tumor derived from notochord remnants. Incidence and Location: Relatively uncommon tumor. Most common sites are sacrococcygeal region (about half), clivus or spheno-occipital region (a third), and associated with articulating vertebrae. Gender and Age Distribution: Any age, more common in adults. Clinical Features: Sacral tumors are marked by pain, sphincter disturbance, and neural deficits secondary to involvement of nerve roots. Base of skull tumors are characterized by headaches, diplopia, and cranial nerve palsies. Radiologic Features: Osseo-destructive mass with infiltration into adjacent soft tissue. Prognosis and Treatment: Wide surgical resection recommended; local recurrence with subtotal resection. Radiotherapy for subtotally resected tumors. Minority of tumors metastasize to the lung, nodes, and skin. Minority of tumors degenerate or dedifferentiate into sarcoma. Younger patients have a better prognosis.
Chordoma. Gross Findings, Microscopic Features, Ultrastructural Features, IHC Features, Genetics, DDx.
Gross Findings: Infiltrative, bone-based, lobulated mass. Mucoid appearance. Cartilaginous tissue in the chondroid variant. Microscopic Features: Lobulated architecture with fibrovascular septa. Epithelioid cells arranged in cords or rows against mucoid stroma. Physaliphorous cells with “bubble-like” vacuolated cytoplasm. Occasional mitotic figures and mild nuclear pleomorphism. Focal cartilaginous differentiation (chondroid chordoma). Ultrastructural Features: Abundant cytoplasmic mucus vacuoles and desmosomal junctions. IHC Features: Positive with antibodies to vimentin, cytokeratins, EMA, and S-100 protein. Genetics: No salient genetic alterations. DDx: Chondrosarcoma. Chordoid meningioma. Metastatic mucinous adenocarcinoma.
Examples of pseudoneoplastic lesions in the nervous system and their related neoplastic mimes.
Gliosis (low-grade gliomas). Active-phase plaques of multiple sclerosis (gliomas). Progressive multifocal leukoencephalopathy (gliomas). Paraventricular glial nodules of tuberous sclerosis (gliomas; gangliogliomas). Viral encephalitides (lymphoma). Other pseudotumors include inflammatory pseudotumor, tumefactive demyelination, radionecrosis, cortical dysplasia, calcified pseudoneoplasm of the neuraxis, meningioangiomatosis, lymphocytic hypophysitis, pineal cyst, and localized hypertrophic neuropathy.
GFAP and vimentin in astroglial cells.
GFAP and vimentin form intermediate filaments in astroglial cells and modulate their motility and shape. In particular, vimentin filaments are present at early developmental stages, while GFAP filaments are characteristic of differentiated and mature brain astrocytes.
Glioneuronal tumors.
… are tumors with an admixture of glial and neuronal components. Both cell types are thought to be part of the same neoplastic process. 3 well-established examples of this class of tumor are: DNETs (dysembryoplastic neuroepithelial tumors), gangliogliomas, and desmoplastic infantile ganglioglioma. More recently recognized entities are: rosette-forming tumor of the fourth ventricle, papillary glioneuronal tumor, rosetted glioneuronal tumor/glioneuronal tumor with neuropil-like islands.
Hemangioblastoma. Definition, Incidence and Location, Gender and Age Distribution, Clinical Features, Radiologic Features, and Prognosis and Treatment.
Definition: Tumor of uncertain histogenesis composed of stromal cells and abundant capillaries. Incidence and Location: Relatively uncommon tumor, 1-3% of intracranial tumors. Most commonly arise in the cerebellum; rarely arise in the brain stem, spinal cord, and supratentorium. Gender and Age Distribution: Slight male preponderance. Peak incidence at 25 to 40 years of age. Von Hippel-Lindau tumors typically develop at a younger age. Clinical Features: Symptoms related to CSF obstruction-increased intracranial pressure. 10% with secondary polycythemia. Radiologic Features: Contrast-enhancing nodule associated with a cyst or syrinx. Prognosis and Treatment: WHO grade I tumor. Good prognosis, curable with gross total resection. Radiotherapy may be of limited use in recurrent or nonresectable tumors. Increased risk of multiple/multifocal tumors in von Hippel-Lindau disease.
Hemangioblastoma. Gross Findings, Microscopic Features, Ultrastructural Features, IHC Features, Genetics, DDx.
Gross Findings: Well-circumscribed tumor with a cystic component and red (vascular) nodule(s). May be yellow if lipid-rich. Microscopic Features: Two components: prominent capillary vasculature and stromal cells with vacuolated or lightly eosinophilic cytoplasm. Stromal cells may demonstrate focal nuclear pleomorphism. Mitoses and necrosis unusual. Adjacent parenchyma gliotic with Rosenthal fibers. Ultrastructural Features: Abundant cytoplasmic lipid droplets in stromal cells. Stromal cell histogenesis not known. IHC Features: Focal vimentin positive; weak GFAP positivity of uncertain significance may be present. Stromal cells generally negative with factor VIII-related antigen, EMA, neurofilament, and keratin antibodies. Stromal cells positive for inhibin A and VEGF. Genetics: Von Hippel-Lindau cases (~25% of tumors) associated with tumor suppressor gene on chromosome 3p25-26. DDx: Metastatic clear cell carcinoma (especially renal cell carcinoma in the setting of von Hippel-Lindau disease). Pilocytic astrocytoma.
In oligodendrogliomas (or tumors with an oligodendroglial component), LOH in what gene is associated with a better response to therapy and a more favorable outcome?
LOH (Loss of Heterozygosity) in 1p19q is associated with a better response to therapy and a more favorable outcome.
List the histologic variants of meningioma, along with WHO grade and pathologic characteristics.
Syncytial (meningotheliomatous); WHO grade I; cells arranged in lobules separated by collagenous septa. Fibrous (fibroblastic); WHO grade I; cells spindled and arranged in interlacing bundles, psammoma bodies and whorling of cells around vessels common. Transitional (mixed); WHO grade I; demonstrates features of both syncytial and fibrous types. Psammomatous; WHO grade I; abundant psammoma bodies, particularly common in the spinal cord. Angiomatous; WHO grade I; numerous blood vessels in the background of an ordinary meningioma. Microcystic; WHO grade I; cells with elongated processes arranged against a loose, mucoid background. Secretory; WHO grade I; intracellular lumina with eosinophilic, PAS-positive material (pseudopsammoma bodies). Lymphoplasmacyte-rich; WHO grade I; extensive chronic inflammatory infiltrates. Metaplastic; WHO grade I; focal mesenchymal differentiation (bone, cartilage, adipose, xanthomatous). Chordoid; WHO grade II; areas resembling chordoma with trabeculae of eosinophilic and vacuolated cells arranged against a myxoid background. Clear cell; WHO grade II; polygonal cells with glycogen-rich, clear cytoplasm. Atypical; WHO grade II; tumor marked by either increased mitotic activity (4 or more mitotic figures per 10 high-power fields - 0.16 mm^2) or 3 or more of the following: increased cellularity, small cell change, prominent nucleoli, sheet-like growth pattern, or necrosis. Papillary; WHO grade III; perivascular pseudopapillary pattern. Rhabdoid; WHO grade III; presence of “rhabdoid cells” with eccentric nuclei and prominent eosinophilic cytoplasmic inclusions of intermediate filaments. Anaplastic (malignant); WHO grade III; tumor marked by either 20 or more mitotic figures per 10 high-power fields (0.16 mm^2) or excessive malignant cytology with an appearance similar to sarcoma, carcinoma, or melanoma.
Meningioma. Definition, Incidence and Location, Gender and Age Distribution, Clinical Features, Radiologic Features, and Prognosis and Treatment.
Definition: Generally slow-growing, dural-based tumors derived from meningothelial (arachnoid cap) cells. Incidence and Location: Account for ~20-30% of primary intracranial neoplasms. Annual incidence rate of ~6-13% per 100,000 persons. Most arise proximal to the dura within the intracranial, orbital, and intravertebral cavities. Most common sites of origin are parasagittal region, cavernous sinus, tuberculum sellae, lamina cribrosa, foramen magnum, and torcular zone. Gender and Age Distribution: Female preponderance, with M:F = 1:1.7. Can occur at any age. Most common in middle-aged and elderly patients, peak during the 6th and 7th decades. Atypical and malignant meningiomas more common in males. Clinical Features: Manifestations dependent on location of tumor. Since they are generally slow growing, they usually produce symptoms by compression of adjacent structures - focal neural deficits, increased intracranial pressure, and seizures are the most common symptoms. May cause hyperostosis of the overlying skull. Radiologic Features: Circumscribed isodense dural masses that enhance with contrast. May show evidence of calcification, bone, or cartilage. Dural tail - wedge-shaped extension of tumor at the edge, contrast enhancing. Malignant and brain invasive tumors associated with cerebral edema. Prognosis and Treatment: Most variants have an excellent prognosis and are curable by gross total resection. Major predictor of recurrence is the extent of surgical resection. Rare, more aggressive variants are more likely to recur and in some cases metastasize. Recurrence rates are 7-20% for WHO grade I, 29-40% for WHO grade II, and 50-78% for WHO grade III. Higher cell proliferative labeling indices correlate with increased risk of recurrence. Radiotherapy used to treat higher grade and aggressive tumors.
Meningioma. Gross Findings, Microscopic Features, Ultrastructural Features, IHC Features, Genetics, DDx.
Gross Findings: Dural-based, sharply demarcated, rubbery or firm mass that compresses adjacent brain parenchyma. Appearance may be altered by lipid content, cystic change, metaplastic components, vascularity, and calcification. Meningioma en plaque - flat growth pattern, most common along the sphenoid wing. Microscopic Features: Monomorphic cells arranged in a syncytium. Nuclei oval to round with inconspicuous nucleoli. Intranuclear pseudoinclusions (cytoplasmic invaginations). Psammoma bodies common. Ultrastructural Features: Prominent intermediate filaments, interdigitating cell processes, and desmosomal intercellular functions. IHC Features: Vimentin-almost all are positive. EMA-~80% focally positive. CEA, cytokeratins-focally positive in a minority of tumors; S-100 protein-20-40% focal positivity. GFAP-negative. Genetics: Most common abnormality-deletion on chromosome 22q. Mutations in the neurofibromatosis 2 gene in 60% of sporadic tumors. DDx: schwannoma, metastatic carcinoma, astrocytoma, sarcoma, solitary fibrous tumor.
Primary GBMs more typically show activation of the ___ pathway, while secondary GBMs more typically show ___ mutations together with other acquired molecular alterations.
Primary GBMs more typically show activation of the EGFR pathway, while secondary GBMs more typically show p53 mutations together with other acquired molecular alterations.
Schwannoma. Definition, Incidence and Location, Gender and Age Distribution, Clinical Features, Radiologic Features, and Prognosis and Treatment.
Definition: Benign tumor derived from Schwann cells; also known as neurilemoma, acoustic neuroma. Incidence and Location: Most frequently arise in association with peripheral nerves, most commonly in the head and neck region and on the extremities. 8% of intracranial and 29% of spinal tumors (extramedullary). Association with neurofibromatosis type 2. Gender and Age Distribution: No gender predilection except for intracranial tumors (F:M = 2:1). Any age, peaks between the fourth and sixth decades. Clinical Features: Most commonly occur as asymptomatic masses. Occasionally with pain, cord compression. CN VIII tumors - hearing loss, facial paresthesias, tinnitus. Radiologic Features: Well-circumscribed, heterogeneously enhancing, sometimes cystic mass. Prognosis and Treatment: Excellent prognosis (WHO grade I), only rarely undergoes malignant degeneration. Curable with surgical resection.
Schwannoma. Gross Findings, Microscopic Features, Ultrastructural Features, IHC Features, Genetics, DDx.
Gross Findings: Circumscribed masses, frequently encapsulated, sometimes cystic. Light tan color; may be yellow (macrophages) or red (hemorrhagic). Microscopic Features: Cells with spindled nuclei, tapered ends. Biphasic cellularity: compact cellular Antoni A pattern and loose microcystic Antoni B pattern. Nuclear palisading - Verocay bodies. Occasional mitotic figures and nuclear pleomorphism acceptable. Sclerotic vessel change common. Cellular variant - hypercellular, predominantly Antoni A pattern. Melanotic schwannoma - may have psammoma bodies (associated with Carney’s complex). Plexiform variant - multinodular, associated with neurofibromatosis type 2. Ultrastructural Features: Cells with convoluted cytoplasmic processes lined by continuous basal lamina. IHC Features: S-100 positive, can be focally GFAP positive. Genetics: NF2 gene (merlin protein) associated with sporadic schwannomas (60%). Subset with chromosome 22q losses. DDx: Fibrous meningioma. Neurofibroma. Sarcoma (especially malignant peripheral nerve sheath tumor). Glioma.
What are primary and secondary GBMs?
Primary GBMs develop de novo. Secondary GBMs develop out of progression of lower-grade infiltrating astrocytomas.
What immunostain reacts with the endothelium of cerebral capillaries, placental vasculature, and juveline capillary angiomas?
GLUT-1.
What primary CNS neoplasms can contain melanin pigment?
Gliomas, medulloblastomas, and schwannomas can contain focal melanin pigment. Melanocytoma and melanoma contain more.
CLIPPERS is a recently described CNS inflammatory condition that should be considered in the DDx when a prominent lymphocytic inflammatory infiltrate is encountered in brainstem, spinal cord, midbrain, or cerebellar biopsies. What does CLIPPERS stand for?
Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids. The inflammatory focus involves the pons with extension into adjacent CNS areas. This entity is a diagnosis of exclusion; histopathologic features must be correlated with the clinical and radiologic findings to arrive at an accurate diagnosis.
What bacterium is the most commonly identified cause of Guillain-Barre syndrome?
C. jejuni, most commonly type O:19, is the most commonly identified cause, implicated in ~30% of cases.
What is Austrian syndrome?
Austrian syndrome was first described by Robert Austrian in 1957. The classical triad consists of meningitis, pneumonia, and endocarditis all caused by Streptococcus pneumoniae. It is associated with alcoholism, due to the presence of hyposplenia, and can been seen in males between 40–60 years old.
HSV 1 is a common cause of (encephalitis and/or meningitis), and HSV 2 is a common cause of (encephalitis and/or meningitis). The best way to diagnose both of these is ___.
HSV 1 is a common cause of encephalitis, and HSV 2 is a common cause of meningitis. The best way to diagnose both of these is CSF PCR.
What tumors are seen in the subtypes of MEN syndrome?
MEN1: Pancreatic tumors (gastrinoma 50%, insulinoma 20-30%, VIPoma 12%, glucagonoma 33%. MEN 2B: Medullary thyroid carcinoma 85%, pheochromocytoma 50%, mucosal neuroma 100%, marfanoid body habitus 80%. FMTC: Medullary thyroid carcinoma 100%.